Skin-brain dialogue in auto-inflammatory diseases: A new route to biomarkers?

被引:0
|
作者
Matar, S. [1 ,2 ,3 ]
Aractingi, S. [1 ,2 ]
Gaillard, R. [3 ,4 ]
Petit, A. C. [3 ,4 ,5 ]
机构
[1] Ctr Univ Paris Cite, Hop Cochin, Dermatol Dept, APHP, Paris, France
[2] Univ Paris Cite, CNRS UMR 8104, INSERM U1016, Inst Cochin,Cutaneous Biol Lab, Paris, France
[3] Univ Psychiat Paris 15, GHU Paris Psychiat & Neurosci, Pole Hosp, Hop Sainte Anne, Paris, France
[4] Univ Paris Cite, Paris, France
[5] Inst Pasteur, CNRS, UMR 3571, Percept & Memory Unit, Paris, France
关键词
Autoinflammatory disease; Skin-brain axis; Psychoneuroimmunology; Neuro-immune-endocrine-cutaneous system; Biomarker; IMMUNE-SYSTEM; DEPRESSION; STRESS; METAANALYSIS; CYTOKINES; DISORDER; ATTACK;
D O I
10.1016/j.bbih.2024.100906
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoinflammatory diseases (AID) are rare systemic inflammatory disorders due to monogenic or polygenic dysfunction of innate immunity. They affect many organs including the brain and the skin. The spectrum of these diseases has been rapidly expanding recently due to newly developed diagnostic tools. The neuro-immunoendocrine-cutaneous interactions play an important role in the pathophysiology of these diseases. The skinbrain interplay is not fully investigated in AID and evidence supporting bidirectional communication is examined. This article provides an overview of the current state of the art in the pathophysiology of AID with cutaneous and psychiatric manifestations. Elucidating the neuro-immuno-endocrine-cutaneous dysregulation underlying pathophysiology of AID is promising for determining future biomarkers and therapeutic options.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Auto-inflammatory diseases
    Michael Hofer
    Pediatric Rheumatology, 12 (Suppl 1)
  • [2] AUTO-INFLAMMATORY DISEASES
    Lachmann, Helen
    RHEUMATOLOGY, 2018, 57
  • [3] Pyogenic auto-inflammatory Diseases
    French, L. E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 46 - 47
  • [4] RECOGNITION AND MANAGEMENT OF THE AUTO-INFLAMMATORY DISEASES
    McGonagle, Dennis
    RHEUMATOLOGY, 2013, 52 : 8 - 8
  • [5] THE CLINICAL SPECTRUM OF AUTO-INFLAMMATORY DISEASES
    Stojanovic, K. Stankovic
    Grateau, G.
    INFLAMMATION RESEARCH, 2011, 60 : 30 - 30
  • [6] Clinical overview of auto-inflammatory diseases
    Georgin-Lavialle, S.
    Rodrigues, F.
    Hentgen, V.
    Fayand, A.
    Quartier, P.
    Bader-Meunier, B.
    Bachmeyer, C.
    Savey, L.
    Louvrier, C.
    Sarrabay, G.
    Melki, I.
    Belot, A.
    Kone-Paut, I.
    Grateau, G.
    REVUE DE MEDECINE INTERNE, 2018, 39 (04): : 214 - 232
  • [7] Myocarditis in auto-immune or auto-inflammatory diseases
    Comarmond, Cloe
    Cacoub, Patrice
    AUTOIMMUNITY REVIEWS, 2017, 16 (08) : 811 - 816
  • [8] Synoviolin is not a pathogenic factor for auto-inflammatory diseases
    Matsumoto, Tatsuaki
    Sato, Yuiko
    Kobayashi, Tami
    Ito, Eri
    Soma, Tomoya
    Kimura, Atsushi
    Miyamoto, Kana
    Kobayashi, Shu
    Harato, Kengo
    Matsumoto, Morio
    Nakamura, Masaya
    Niki, Yasuo
    Miyamoto, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 558 : 183 - 188
  • [9] Update on Auto-inflammatory Diseases and Familial Mediterranean Fever
    Berkun, Yackov
    Eisenstein, Eli M.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (3-4): : 221 - 224
  • [10] MONOGENIC AUTO-INFLAMMATORY DISEASES IN ADULTS IN THE PRACTICE OF A RHEUMATOLOGIST
    Salugina, S.
    Fedorov, E.
    Dubinina, T.
    Palshina, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 962 - 962